Eyenovia Inc — Company Overview, News & Financial Data

Eyenovia (NASDAQ:EYEN) is pioneering a new approach to eye care through its development of microdosing technology for ophthalmic treatments. The company is traded on the NASDAQ exchange. Eyenovia focuses on creating advanced therapeutic solutions using its proprietary Optejet device, which administers precise microdoses of medication to the eye, potentially enhancing efficacy and reducing side effects. Their pipeline includes innovative treatments for myopia progression, presbyopia, and other eye-related conditions, aiming to provide user-friendly alternatives to traditional eye drops. By prioritizing precision and patient convenience, Eyenovia is set on transforming how eye conditions are managed, with a commitment to enhancing patients' lives through cutting-edge ocular science.